Jill L. Robinson - 11 Dec 2025 Form 4 Insider Report for Atlanta Braves Holdings, Inc. (BATRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Dec 2025, 16:02:34 UTC
Prior SEC filing
08 Dec 2025
Next SEC filing
03 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kerry T. Wenzel, Attorney-in-Fact

Key filing fact

Jill L. Robinson filed Form 4 for Atlanta Braves Holdings, Inc. (BATRA) on 15 Dec 2025.

Key facts

  • This page summarizes Jill L. Robinson's Form 4 filing for Atlanta Braves Holdings, Inc. (BATRA).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Dec 2025, 16:02.

Change

  • Previous filing in this sequence was filed on 08 Dec 2025.
  • Current net transaction value: -$152,051.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002036189 Primary reporting owner

Robinson Jill L.

Relationship
EVP, CFO & Treasurer
Address
C/O ATLANTA BRAVES HOLDINGS, INC., 755 BATTERY AVENUE SE, ATLANTA
Signature
/s/ Kerry T. Wenzel, Attorney-in-Fact
Signature date
15 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BATRK transaction

Series C Common Stock

Options Exercise

Transaction value
$0
Shares
+7,660
Change %
+10%
Price
$0.000000
Shares after
83,290
Date
11 Dec 2025
Ownership
Direct
Footnotes
F1
BATRK transaction

Series C Common Stock

Sale

Transaction value
$152,051
Shares
-3,830
Change %
-4.6%
Price
$39.70
Shares after
79,460
Date
12 Dec 2025
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BATRK transaction Derivative

Restricted Stock Units - BATRK

Options Exercise

Transaction value
$0
Shares
-7,660
Change %
-50%
Price
$0.000000
Shares after
7,661
Date
11 Dec 2025
Ownership
Direct
Underlying class
Series C Common Stock
Underlying amount
7,660
Exercise price
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Each restricted stock unit converted into one share of Series C Common Stock.

Footnote F2

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2025 and was intended to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

Footnote F3

Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

Footnote F5

One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .